Navigation Links
HHS enlists Archimedes Inc. to expand government's use of health care modeling
Date:5/3/2012

(San Francisco CA and Princeton NJ) -- To put high-powered mathematical analytics in the hands of its agencies, the U.S. Department of Health and Human Services (HHS) has contracted with Archimedes Inc., a healthcare modeling company based in San Francisco CA. The contract will put the Archimedes model at the fingertips of its agencies, enabling them to research, analyze, and evaluate the effects of specific health care interventions more quickly and accurately.

The Archimedes Model, developed initially with support from Kaiser Permanente, is the most advanced mathematical modeling tool available to answer complex questions on health and health care. Under this contract, HHS will make a new web-based interface called the Archimedes Healthcare Simulator (ARCHeS) available to its agencies, including the Centers for Medicare and Medicaid Services, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, the National Heart, Lung & Blood Institute and the Food & Drug Administration in order to help better:

  • Analyze prevention activities and management of chronic conditions for patients;
  • Design guidelines, performance measures, and incentive programs, such as pay-for-performance;
  • Assess technologies and compare the effectiveness of different treatments;
  • Design clinical trials;
  • Analyze and improve health processes;
  • Forecast the costs of healthcare; and
  • Estimate the cost effectiveness of interventions.

HHS' ability to offer agencies widespread access to this revolutionary tool in clinical care and research was spurred by the Robert Wood Johnson Foundation (RWJF) Pioneer Portfolio, which, in 2007, provided a $15.6 million grant to support the creation of ARCHeS, which makes the Archimedes Model more accessible and affordable for public policymakers and nonprofit users.

"When we initially made this grant, I said that the development of ARCHeS would usher in a new era in medical decision-making that we believe has the potential to transform health and health care," said Risa Lavizzo-Mourey, MD, president and CEO of the Robert Wood Johnson Foundation. "By getting ARCHeS in the hands of HHS and all of its agencies, we've taken a very big step toward realizing that potential. Our goal has always been to create access to this innovation for the public policymakers and researchers best positioned to use it to inform decisions that will improve health and health care for all Americans. We now see that happening."

"The quality and cost of health care are determined by decisions made by policymakers, physicians and others. To make those decisions wisely, decision makers need to know the consequences of the different options they face. For a high proportion of decisions, the only feasible way to get the needed information is to use mathematical models that integrate existing evidence, and are validated against evidence," said David Eddy, MD, PhD, Founder and Chief Medical Officer of Archimedes. "This agreement with HHS puts the analytical power of advanced health care modeling on the desks of decision makers in the federal government. By combining this tool with their own insights and experience, decision makers will be able to understand much better the effects of different policies, and be able to design policies that achieve the twin goals of improving quality and controlling costs."

In one of a number of important analyses already performed by Archimedes, Kaiser Permanente used forecasts from the model as the impetus to launch a program to provide a bundle of aspirin, lovastatin (a cholesterol-lowering drug), and lisinopril (a blood pressure-reducing drug), to high-risk members. This analysis was used in informing the implementation of Kaiser Permanente's ALL/PHASE program. The result was a more than 60% reduction in heart attacks and strokes over a two-year period.

As a result of the Health Information Technology for Economic and Clinical Health (HITECH) Act and the Patient Protection and Affordable Care Act, the use of modeling and simulation platforms is in high demand for policymakers and researchers. Both of these laws include new requirements for use of data in the design of health benefits; comparative effectiveness of quality, cost, and outcomes; and evaluation of population health efforts. In March, the federal government launched a major research initiative in big data computing for a number of agencies, including the National Institutes of Health.

"The federal government sees a growing need across all of its agencies for innovative resources to aid in research, policy analysis and evaluation," said Todd Park, former Chief Technology Officer for HHS, and newly appointed Chief Technology Officer to the United States. "We're excited that ARCHeS will now be available to staff across the Department of Health and Human Services. It gives us an important new tool to analyze a wide variety of health policy questions and quickly compare different scenarios and outcomes."


'/>"/>

Contact: Janet Firshein
jfirshein@burnesscommunications.com
301-652-1558
Burness Communications
Source:Eurekalert

Related medicine news :

1. New model for studying germ cell tumors in testes enlists embryonic stem cells
2. Archimedes Pharma Announces Major Fund Raising of GBP65 Million
3. Stem Cell Finding Could Expand Womens Lifetime Supply of Eggs
4. $10.5 million grant will expand vast online hub for educators, by educators
5. Mass. Life Sciences Center grant expands Dana-Farbers cancer imaging research
6. Expanding treatment options for Cushing disease
7. Study identifies an expanded role for PKM2 in helping cancer cells survive
8. Expanding HIV treatment for discordant couples could significantly reduce global HIV epidemic
9. AAP expands guidelines for infant sleep safety and SIDS risk reduction
10. AAP expands ages for diagnosis and treatment of ADHD in children
11. Landmark law and neuroscience network expands at Vanderbilt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Airway ... new partnership with the highly regarded and well renowned Asian distributor, Discovery Sleep. ... & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen Airway’s presence ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... imaging practices, is seeking candidates to serve on its Accreditation and Standards ... , “RadSite’s ultimate mission is improving image quality and reducing patient radiation ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... ... ... During April 21-23, Super-Sod will join the vendor market of the Sacred Heart ... from the avid gardener to the landscape admirer — during the three-day schedule. , ... grand venue, and we are certainly looking forward to participating in this year’s festival,” ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... Service Provider, announces a significant bandwidth upgrade infrastructure service to Tele-Media Solutions. ... Solutions. One of IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: